New therapies for heart and lung diseases

The Swedish CArdioPulmonarybioImage Study (SCAPIS) combines the use of new imaging technologies, advances in large-scale omics, Swedish registers and epidemiological analyses and wellness profiling. The information obtained will be used to combat cardiopulmonary diseases.

The seminar. organized by IVA’s division for Biotechnology, presents the latest developments in the project and the potential for future research by collaborations with major Swedish research infrastructures.

PROGRAM

Welcome
Inger Andersson, Chairman of the Division for Biotechnology

Introduction
Staffan Josephson, Division for Biotechnology

SCAPIS – Sweden’s largest, most comprehensive study on cardiac and pulmonary disease
Professor Göran Bergström, Senior Physician, Wallenberg Laboratory, University of Gothenburg.

The merge of large scale population studies and registers – a unique competitive edge for Swedish research
Professor Annika Rosengren, Sahlgrenska University Hospital.

Deep molecular profiling meets large scale epidemiology to promote health
Professor Mathias Uhlén, Science for Life Laboratory and Albanova University Center KTH.

DHR wellness profiling project at FIMM: molecular health profiles during a lifestyle change
Professor Olli Kallioniemi, MD, PhD Director of the Science for Life Laboratory, Molecular Precision Medicine Karolinska Institutet.